Global Brain Cancer Targeted Drug Supply, Demand and Key Producers, 2023-2029
Page: 76
Published Date: 03 Feb 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Related Reports
- Product Tags
Description
The global Brain Cancer Targeted Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist.
This report studies the global Brain Cancer Targeted Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Brain Cancer Targeted Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Brain Cancer Targeted Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Brain Cancer Targeted Drug total market, 2018-2029, (USD Million)
Global Brain Cancer Targeted Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Brain Cancer Targeted Drug total market, key domestic companies and share, (USD Million)
Global Brain Cancer Targeted Drug revenue by player and market share 2018-2023, (USD Million)
Global Brain Cancer Targeted Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Brain Cancer Targeted Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Brain Cancer Targeted Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Roche and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Brain Cancer Targeted Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Brain Cancer Targeted Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Brain Cancer Targeted Drug Market, Segmentation by Type
Belzutifan (Welireg)
Bevacizumab (Avastin)
Everolimus (Afinitor)
Global Brain Cancer Targeted Drug Market, Segmentation by Application
Hospital
Retail Pharmacy
Other
Companies Profiled:
Merck & Co.
Roche
Novartis
Key Questions Answered
1. How big is the global Brain Cancer Targeted Drug market?
2. What is the demand of the global Brain Cancer Targeted Drug market?
3. What is the year over year growth of the global Brain Cancer Targeted Drug market?
4. What is the total value of the global Brain Cancer Targeted Drug market?
5. Who are the major players in the global Brain Cancer Targeted Drug market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Brain Cancer Targeted Drug Introduction
1.2 World Brain Cancer Targeted Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Brain Cancer Targeted Drug Total Market by Region (by Headquarter Location)
1.3.1 World Brain Cancer Targeted Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Brain Cancer Targeted Drug Market Size (2018-2029)
1.3.3 China Brain Cancer Targeted Drug Market Size (2018-2029)
1.3.4 Europe Brain Cancer Targeted Drug Market Size (2018-2029)
1.3.5 Japan Brain Cancer Targeted Drug Market Size (2018-2029)
1.3.6 South Korea Brain Cancer Targeted Drug Market Size (2018-2029)
1.3.7 ASEAN Brain Cancer Targeted Drug Market Size (2018-2029)
1.3.8 India Brain Cancer Targeted Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Brain Cancer Targeted Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Brain Cancer Targeted Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 Demand Summary
2.1 World Brain Cancer Targeted Drug Consumption Value (2018-2029)
2.2 World Brain Cancer Targeted Drug Consumption Value by Region
2.2.1 World Brain Cancer Targeted Drug Consumption Value by Region (2018-2023)
2.2.2 World Brain Cancer Targeted Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Brain Cancer Targeted Drug Consumption Value (2018-2029)
2.4 China Brain Cancer Targeted Drug Consumption Value (2018-2029)
2.5 Europe Brain Cancer Targeted Drug Consumption Value (2018-2029)
2.6 Japan Brain Cancer Targeted Drug Consumption Value (2018-2029)
2.7 South Korea Brain Cancer Targeted Drug Consumption Value (2018-2029)
2.8 ASEAN Brain Cancer Targeted Drug Consumption Value (2018-2029)
2.9 India Brain Cancer Targeted Drug Consumption Value (2018-2029)
3 World Brain Cancer Targeted Drug Companies Competitive Analysis
3.1 World Brain Cancer Targeted Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Brain Cancer Targeted Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Brain Cancer Targeted Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Brain Cancer Targeted Drug in 2022
3.3 Brain Cancer Targeted Drug Company Evaluation Quadrant
3.4 Brain Cancer Targeted Drug Market: Overall Company Footprint Analysis
3.4.1 Brain Cancer Targeted Drug Market: Region Footprint
3.4.2 Brain Cancer Targeted Drug Market: Company Product Type Footprint
3.4.3 Brain Cancer Targeted Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Brain Cancer Targeted Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Brain Cancer Targeted Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Brain Cancer Targeted Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Brain Cancer Targeted Drug Consumption Value Comparison
4.2.1 United States VS China: Brain Cancer Targeted Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Brain Cancer Targeted Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Brain Cancer Targeted Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Brain Cancer Targeted Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Brain Cancer Targeted Drug Revenue, (2018-2023)
4.4 China Based Companies Brain Cancer Targeted Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Brain Cancer Targeted Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Brain Cancer Targeted Drug Revenue, (2018-2023)
4.5 Rest of World Based Brain Cancer Targeted Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Brain Cancer Targeted Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Brain Cancer Targeted Drug Revenue, (2018-2023)
5 Market Analysis by Type
5.1 World Brain Cancer Targeted Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Belzutifan (Welireg)
5.2.2 Bevacizumab (Avastin)
5.2.3 Everolimus (Afinitor)
5.3 Market Segment by Type
5.3.1 World Brain Cancer Targeted Drug Market Size by Type (2018-2023)
5.3.2 World Brain Cancer Targeted Drug Market Size by Type (2024-2029)
5.3.3 World Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2029)
6 Market Analysis by Application
6.1 World Brain Cancer Targeted Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Brain Cancer Targeted Drug Market Size by Application (2018-2023)
6.3.2 World Brain Cancer Targeted Drug Market Size by Application (2024-2029)
6.3.3 World Brain Cancer Targeted Drug Market Size by Application (2018-2029)
7 Company Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Details
7.1.2 Merck & Co. Major Business
7.1.3 Merck & Co. Brain Cancer Targeted Drug Product and Services
7.1.4 Merck & Co. Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Merck & Co. Recent Developments/Updates
7.1.6 Merck & Co. Competitive Strengths & Weaknesses
7.2 Roche
7.2.1 Roche Details
7.2.2 Roche Major Business
7.2.3 Roche Brain Cancer Targeted Drug Product and Services
7.2.4 Roche Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Roche Recent Developments/Updates
7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Brain Cancer Targeted Drug Product and Services
7.3.4 Novartis Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Brain Cancer Targeted Drug Industry Chain
8.2 Brain Cancer Targeted Drug Upstream Analysis
8.3 Brain Cancer Targeted Drug Midstream Analysis
8.4 Brain Cancer Targeted Drug Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Brain Cancer Targeted Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Brain Cancer Targeted Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Brain Cancer Targeted Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Brain Cancer Targeted Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Brain Cancer Targeted Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Brain Cancer Targeted Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Brain Cancer Targeted Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Brain Cancer Targeted Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Brain Cancer Targeted Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Brain Cancer Targeted Drug Players in 2022
Table 12. World Brain Cancer Targeted Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Brain Cancer Targeted Drug Company Evaluation Quadrant
Table 14. Head Office of Key Brain Cancer Targeted Drug Player
Table 15. Brain Cancer Targeted Drug Market: Company Product Type Footprint
Table 16. Brain Cancer Targeted Drug Market: Company Product Application Footprint
Table 17. Brain Cancer Targeted Drug Mergers & Acquisitions Activity
Table 18. United States VS China Brain Cancer Targeted Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Brain Cancer Targeted Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Brain Cancer Targeted Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Brain Cancer Targeted Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Brain Cancer Targeted Drug Revenue Market Share (2018-2023)
Table 23. China Based Brain Cancer Targeted Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Brain Cancer Targeted Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Brain Cancer Targeted Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Brain Cancer Targeted Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Brain Cancer Targeted Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Brain Cancer Targeted Drug Revenue Market Share (2018-2023)
Table 29. World Brain Cancer Targeted Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Brain Cancer Targeted Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Brain Cancer Targeted Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Brain Cancer Targeted Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Brain Cancer Targeted Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Brain Cancer Targeted Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Merck & Co. Basic Information, Area Served and Competitors
Table 36. Merck & Co. Major Business
Table 37. Merck & Co. Brain Cancer Targeted Drug Product and Services
Table 38. Merck & Co. Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck & Co. Recent Developments/Updates
Table 40. Merck & Co. Competitive Strengths & Weaknesses
Table 41. Roche Basic Information, Area Served and Competitors
Table 42. Roche Major Business
Table 43. Roche Brain Cancer Targeted Drug Product and Services
Table 44. Roche Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Novartis Basic Information, Area Served and Competitors
Table 47. Novartis Major Business
Table 48. Novartis Brain Cancer Targeted Drug Product and Services
Table 49. Novartis Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 50. Global Key Players of Brain Cancer Targeted Drug Upstream (Raw Materials)
Table 51. Brain Cancer Targeted Drug Typical Customers
List of Figure
Figure 1. Brain Cancer Targeted Drug Picture
Figure 2. World Brain Cancer Targeted Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Brain Cancer Targeted Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Brain Cancer Targeted Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Brain Cancer Targeted Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Brain Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Brain Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Brain Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Brain Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Brain Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Brain Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Brain Cancer Targeted Drug Revenue (2018-2029) & (USD Million)
Figure 13. Brain Cancer Targeted Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Brain Cancer Targeted Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Brain Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Brain Cancer Targeted Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Brain Cancer Targeted Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Brain Cancer Targeted Drug Markets in 2022
Figure 27. United States VS China: Brain Cancer Targeted Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Brain Cancer Targeted Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Brain Cancer Targeted Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Brain Cancer Targeted Drug Market Size Market Share by Type in 2022
Figure 31. Belzutifan (Welireg)
Figure 32. Bevacizumab (Avastin)
Figure 33. Everolimus (Afinitor)
Figure 34. World Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Brain Cancer Targeted Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Brain Cancer Targeted Drug Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Retail Pharmacy
Figure 39. Other
Figure 40. Brain Cancer Targeted Drug Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>